The Instantaneous Wave-Free Ratio is Equivalent to Fractional Flow Reserve and does not require adenosine.

Original title: Diagnostic Classification of the Instantaneous Wave-Free Ratio Is Equivalent to Fractional Flow Reserve and Is Not Improved With Adenosine Administration. Results of CLARIFY (Classification Accuracy of Pressure-Only Ratios Against Indices Using Flow Study. Reference: Sayan Sen et al. J Am Coll Cardiol 2013;61:1409–20.

When considering revascularization, measuring lesion functional compromise is known to improve clinical outcomes and reduce costs. Intracoronary pressure distal to a stenosis reflects not only the severity of the stenosis but also the pressure generated from microcirculation. Fractional Flow Reserve (FFR) calculates the pressure distal to a stenosis and the aorta during a whole cardiac cycle, but in order to separate epicardial lesion values from microcirculation values requires adenosine administration.

The instantaneous wave-free ratio of cardiac cycle (iFR) is an alternative index that does not require adenosine administration or any other vessel dilator, since during this period, microcirculation resistance is naturally constant and minimized. Intracoronary pressure and flow velocity was measured distal to the stenosis at rest and during adenosine administration (ComboWire XT,Volcano Corporation, San Diego, California) in 51 vessels. iFR ratio was calculated as the relationship between mean distal pressure and proximal pressure during the wave-free diastolic period.

Diagnosis matched in 47 of the 51 lesions (92.3%); no significant differences were observed in the area under the ROC curves (p=0.15). iFR ratio showed a trans-stenosis pressure gradient equivalent to that of FFR ratio (iFR 8.2 mmHg vs 12.2 mmHg; p=0.48) with an 0.86 iFR comparable to a 0.75 FFR.

Conclusion: 

iFR and FFR were equivalent when classifying coronary stenosis severity. Adenosine administration did not improve diagnostic categorization, indicating that iFR can be used as an adenosine-free alternative to FFR and that adenosine administration is not required.

Editorial Comment: 

The ADVISE study used different cut-offs, which resulted in a 0.89 iFR, equivalent to a 0.8 FFR. However, although physiology guided revascularization has shown to be effective, it has seen limited practice and perhaps one of the reasons is the need to administer adenosine, which requires the use of a large number of doses to reach the recommended infusion level, increases cost and, in addition, has frequent, though transitory, adverse effects (shortness of breath, chest pain, blushing, AV block). iFR is much more practical but its real value calls for further research to assess clinical end points. 

SOLACI.ORG

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroSMR Registry: Edge-to-Edge Mitral Treatment with 5-Year Outcomes

Cardiomyopathies and left atrial enlargement can lead to secondary mitral regurgitation (SMR). This condition is associated with ventricular dysfunction, causing heart failure, hospitalization, and...

TricValve Transcatheter Bicaval Valve System for Severe Tricuspid Insufficiency: Events at One Year

TricValve is the first bicaval valve system to obtain CE-Mark approval. This device heterotopic device eliminates tricuspid insufficiency reflux into the venous system, reducing...

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...